113 related articles for article (PubMed ID: 1970484)
21. Loss of allelic heterozygosity at the harvey ras locus in human oral carcinomas.
Saranath D; Bhoite LT; Mehta AR; Sanghavi V; Deo MG
J Cancer Res Clin Oncol; 1991; 117(5):484-8. PubMed ID: 1679760
[TBL] [Abstract][Full Text] [Related]
22. Functional genetic variants of CTLA-4 and risk of tobacco-related oral carcinoma in high-risk North Indian population.
Bharti V; Mohanti BK; Das SN
Hum Immunol; 2013 Mar; 74(3):348-52. PubMed ID: 23246583
[TBL] [Abstract][Full Text] [Related]
23. Elevated frequency of a specific allele of the L-myc gene in male patients with bone and soft-tissue sarcomas.
Kato M; Toguchida J; Honda K; Sasaki MS; Ikenaga M; Sugimoto M; Yamaguchi T; Kotoura Y; Yamamuro T; Ishizaki K
Int J Cancer; 1990 Jan; 45(1):47-9. PubMed ID: 1967596
[TBL] [Abstract][Full Text] [Related]
24. Angiotensinogen polymorphism is associated with risk for malignancy but not for oral cancer.
Vairaktaris E; Yapijakis C; Vylliotis A; Derka S; Vassiliou S; Nkenke E; Serefoglou Z; Ragos V; Critselis E; Avgoustidis D; Neukam F; Patsouris E
Anticancer Res; 2008; 28(3A):1675-9. PubMed ID: 18630525
[TBL] [Abstract][Full Text] [Related]
25. Loss of Harvey ras heterozygosity in oral squamous carcinoma.
Howell RE; Wong FS; Fenwick RG
J Oral Pathol Med; 1989 Feb; 18(2):79-83. PubMed ID: 2568483
[TBL] [Abstract][Full Text] [Related]
26. L-myc restriction fragment length polymorphism and histological pattern of invasion in lung adenocarcinoma.
Suzuki H; Yamashiro K
Oncol Rep; 2002; 9(2):345-7. PubMed ID: 11836605
[TBL] [Abstract][Full Text] [Related]
27. Is Human Oxoguanine Glycosylase 1 Genetic Variant Successful Even on Oral Squamous Cell Carcinoma?
Aydemir L; Bireller ES; Avci H; Boy Metin Z; Deger K; Unur M; Cakmakoglu B
Pathobiology; 2017; 84(4):223-228. PubMed ID: 28448977
[TBL] [Abstract][Full Text] [Related]
28. EcoRI polymorphism of the L-myc gene in gastric cancer patients.
Dlugosz A; Adler G; Ciechanowicz A; Jaroszewicz-Heigelmann H; Starzynska T
Eur J Gastroenterol Hepatol; 2002 Nov; 14(11):1231-5. PubMed ID: 12439118
[TBL] [Abstract][Full Text] [Related]
29. L-myc restriction fragment length polymorphism in Japanese patients with esophageal cancer.
Shibuta K; Inoue H; Sato K; Matsuyama A; Ueo H; Tanaka Y; Mafune K; Barnard GF; Mori M
Jpn J Cancer Res; 2000 Feb; 91(2):199-203. PubMed ID: 10761707
[TBL] [Abstract][Full Text] [Related]
30. Rflp analysis of the L-myc oncogene in head and neck-cancer - relationship study with susceptibility and disease progression.
Millon R; Muller D; Velten M; Doffoel S; Eber M; Engelmann A; Bronner G; Flesch H; Methlin G; Abecassis J
Int J Oncol; 1995 Jan; 6(1):237-42. PubMed ID: 21556529
[TBL] [Abstract][Full Text] [Related]
31. A DNA polymorphism of stromal-derived factor-1 is associated with advanced stages of oral cancer.
Vairaktaris E; Vylliotis A; Spyridonodou S; Derka S; Vassiliou S; Nkenke E; Yapijakis C; Serefoglou Z; Neukam FW; Patsouris E
Anticancer Res; 2008; 28(1A):271-5. PubMed ID: 18383856
[TBL] [Abstract][Full Text] [Related]
32. Retrospective case-control study of correlation between MTHFR gene and OSCC risk in North India.
Naqvi H; Ahmad MK; Hussain SR; Gupta S; Waseem M; Mahdi AA
Clin Oral Investig; 2017 Jul; 21(6):1929-1934. PubMed ID: 27774577
[TBL] [Abstract][Full Text] [Related]
33. L-myc polymorphism in head and neck nonmelanoma skin and lower lip cancers.
Gözü A; Ergen A; Dayicioglu D; Yaylim I; Ozsoy Z; Isbir T
Arch Otolaryngol Head Neck Surg; 2008 Jul; 134(7):725-8. PubMed ID: 18645122
[TBL] [Abstract][Full Text] [Related]
34. No correlation between L-myc restriction fragment length polymorphism and malignancy of human colorectal cancers.
Ikeda I; Ishizaka Y; Ochiai M; Sakai R; Itabashi M; Onda M; Sugimura T; Nagao M
Jpn J Cancer Res; 1988 Jun; 79(6):674-6. PubMed ID: 2900827
[TBL] [Abstract][Full Text] [Related]
35. Association of the XPD and XRCC3 gene polymorphisms with oral squamous cell carcinoma in a Northeastern Brazilian population: A pilot study.
dos Santos Pereira J; Fontes FL; de Medeiros SR; de Almeida Freitas R; de Souza LB; da Costa Miguel MC
Arch Oral Biol; 2016 Apr; 64():19-23. PubMed ID: 26742000
[TBL] [Abstract][Full Text] [Related]
36. Association of polymorphisms in Tumor Necrosis Factor Alpha and Beta genes with increased risk for oral cancer.
Yapijakis C; Serefoglou Z; Vylliotis A; Nkenke E; Derka S; Vassiliou S; Avgoustidis D; Neukam FW; Patsouris E; Vairaktaris E
Anticancer Res; 2009 Jun; 29(6):2379-86. PubMed ID: 19528505
[TBL] [Abstract][Full Text] [Related]
37. Association between restriction fragment length polymorphism of the L-myc gene and lung metastasis in human breast cancer.
Champeme MH; Bieche I; Latil A; Hacene K; Lidereau R
Int J Cancer; 1992 Jan; 50(1):6-9. PubMed ID: 1345822
[TBL] [Abstract][Full Text] [Related]
38. Tumor necrosis factor-alpha promoter polymorphism is associated with susceptibility to oral squamous cell carcinoma.
Liu CJ; Wong YK; Chang KW; Chang HC; Liu HF; Lee YJ
J Oral Pathol Med; 2005 Nov; 34(10):608-12. PubMed ID: 16202081
[TBL] [Abstract][Full Text] [Related]
39. Single nucleotide polymorphism in hMLH1 promoter and risk of tobacco-related oral carcinoma in high-risk Asian Indians.
Jha R; Gaur P; Sharma SC; Das SN
Gene; 2013 Sep; 526(2):223-7. PubMed ID: 23727610
[TBL] [Abstract][Full Text] [Related]
40. Evidence against a tumour-specific EcoRI RFLP of the c-mos locus.
Corell B; Zoll B
FEBS Lett; 1988 Mar; 230(1-2):81-4. PubMed ID: 2895024
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
